LYMESEQ trademarks | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks

exact LYMESEQ exact LYMESEQ

Trademarks matching 'lymeseq'

Summary of page content
2020-03-16
US
Trademark Image
The mark consists of the word "Lymeseq" in stylized gray letters beside a stylized design of a light green circle with yellow, dark green, green and white vertical bars appearing inside.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    medical test kits comprised of diagnosing reagents and assays for diagnosing lyme disease
688
NOTICE OF ALLOWANCE - ISSUED
2021-04-06
2021-04-06
LYMESEQ LymeSeq, LLC
2019-02-25
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    medical test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, lyme disease
  • 35
    Advertising; business management; business administration; office functions
    promoting collaboration within the scientific, research and medical communities to achieve advances in the field of lyme disease; promoting public awareness of lyme disease
  • 36
    Insurance; financial affairs; monetary affairs; real estate affairs
    financial services, namely, funding research in the field of lyme disease
732
THIRD EXTENSION - GRANTED
2021-03-01
2021-03-03
LYMESEQ LymeSeq, LLC
2016-07-28
US
Trademark Image
The mark consists of the word "LIMESEQ" in gray letters to the left of a solid green circle with three segmented bars running vertically within the circle. The left bar is yellow and is split in half with space between the halves. The middle bar consists of two joined segments, the upper smaller segment being a darker green and the lower segment being white. The middle bar's length is a little more than half the diameter of the green circle. The right bar consists of two segments with space between the segments. The upper smaller segment is a medium green and the lower segment is white. The right bar's length is a little more than half the diameter of the solid green circle. The remaining white in the drawing indicates transparent background areas and is not claimed as a feature of the mark.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    medical test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, lyme disease
606
ABANDONED - NO STATEMENT OF USE FILED
2020-03-17
2020-05-31
LYMESEQ LymeSeq, LLC
2016-08-19
US
  • 1
    Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
    diagnostic reagents for laboratory use, namely, for clinical, medical, or epidemiological laboratory use; chemical preparations for scientific purposes; reagents for use in scientific apparatus for chemical or biological analysis; testing kits containing reagents used in analyzing and detecting certain microorganisms for clinical, medical, or epidemiological laboratory use; microbiological genetic identity tests comprised of reagents for scientific research; biomedical compounds, namely, substrates used in analyzing and detecting certain nucleic acids for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use in science, namely, for clinical, medical, or epidemiological laboratory use; medical diagnostic reagents for the analysis of body fluids; microbiological genetic identity tests for medical purposes comprised of reagents; diagnostic preparations for laboratory use, namely, for medical use; clinical medical reagents; diagnostic kits for medical use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids or microbiological specimens; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids or microbiological specimens; medical diagnostic test kits comprised of reagents and assays for testing of body fluids or microbiological specimens; computer software for healthcare monitoring, namely, monitoring healthcare-acquired infections or community-acquired infections; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between testing facilities and health care professionals; mobile electronic devices, namely, personal digital assistants, tablet computers, mobile phones, laptop computers, and smartphones; laboratory apparatus, for use in medical laboratories, for analysis of body fluids and tissue; medical and scientific research in the field of microbiological testing and diagnosis and treatment of medical conditions; development and laboratory testing in the field of microbiological-caused human disease; scientific research consulting in the field of microbiological-based genetics, genomics, dna sequencing, and bioinformatics; genetic research, development and testing services; genomic research, development and testing services for scientific research purposes; dna collection, testing and analysis services for scientific research purposes; genetic testing for scientific research purposes; genomic testing for scientific research purposes; medical and scientific research, development and consulting in the field of infectious diseases; medical and scientific research in the field of genetics and genetic engineering; medical and scientific research and consulting in the fields of genomics and next generation sequencing; medical and scientific research in the field of infectious disease diagnosis epidemiology; data collection for research purposes, namely, the collection, testing and research of patient specimen molecular and/or genomic data; compiling genomic data for research purposes in the field of medical science; dna-sequencing for scientific research purposes; genotyping; gene screening; consulting services in the field of microbiology; medical and scientific research services in the field of health care; scientific research consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; biological research; biomedical research; laboratory research in the field of microbiology, biochemistry, biology, health and medicine; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, namely, disease biology; scientific laboratory services; software as a service (saas) for medical and disease analysis; medical testing for diagnostic or treatment purposes in the field of infectious diseases; medical diagnostic testing, monitoring and reporting services; medical evaluation services, namely, for evaluation of presence of infectious diseases; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing, namely, determination of antibiotic resistance of microorganisms; collection and preservation of dna for medical and research purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare, insurance reimbursement, and microbiology; genetic testing for scientific diagnostic purposes; genomic testing for scientific diagnostic purposes; genotype-based testing for medical purposes; providing information in the field of infectious disease prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; microbiological screening for medical diagnostic purposes; medical care consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; consulting services in the nature of providing information about medical services; consulting services in the field of insurance reimbursement; consulting services in the nature of providing information about insurance reimbursement; consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical conditions, including healthcare-acquired infections or community-acquired infections; education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and insurance field; educational services, namely, seminars and educational conventions
602
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
2017-06-30
2020-05-31
center medicine clinical science education technology cancer global oncology als drug development association treat advancing therapy atlantis celgene europe collaborative
First 1 Last  1 of 1
NEED HELP? Chat with us online

Copyright 2008 - 2024 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.